Module 1: Introduction to NADclinic, Longevity Medicine and Precision Health

What NADclinic is and how the four pillars of the business model work, the global longevity opportunity and the lifespan against healthspan distinction, NAD+ explained in language a client can use, the Six Pillars of Wellness framework applied across age, gender and heritage, the practitioner's role and scope of practice guide, and why pre-therapy assessment is non-negotiable.

Module 2: The Science of NAD+, Mitochondria and Cellular Ageing

The molecular structure and core functions of NAD+, the four biosynthesis pathways and the rate-limiting role of NAMPT, the four families of consuming enzymes including CD38 and PARP, mitochondrial function and the NAD+ to NADH redox ratio, the NAD+ Triad, the age decline curve, seven of the nine hallmarks of ageing, the circadian connection, and the pre-therapy biomarkers that reflect NAD+ status.

Module 3: NADclinic Product Portfolio and Therapeutic Applications

Bioavailability across six delivery routes, the intravenous range with dosing bands, infusion rate limits and side effect management, the Myers Cocktail pre-load and G6PD screening, subcutaneous Smart Pen and vial formats, inhaled delivery, the oral daily baseline, the longevity supplement stack with interaction cautions, exosome therapy, peptides, methylene blue and its serotonergic contraindication, product selection by demographic, and storage and quality control.

Module 4: Diagnostics, Functional Testing and Precision Assessment

The mandatory minimum pre-therapy panel with a defined action for every abnormal result, telomere and epigenetic biological age testing and which clock to use for which job, the four-tier diagnostic panel structure, metabolic, cardiovascular, hormonal, inflammatory and nutritional markers read against functional optimum ranges, five genetic variants that change protocols, wearables and continuous glucose data, ethnicity-specific testing modifications, and a five-step interpretation framework.

Module 5: Precision Product Selection and Clinical Decision Making

The Five Rights framework applied end to end, the three-step route decision tree, seven population-specific protocols covering perimenopause, post-menopause, male andropause, athletic performance, executive burnout, healthy ageing and Long COVID, ethnicity-specific protocol modifications, the full contraindication table read route by route, the session-by-session pre-treatment checklist, and the KPI framework with defined adjustment triggers.

Module 6: Programme Design, Protocol Building and Client Action Planning

The five-step protocol design framework, the three-phase programme architecture of foundation, restoration and optimisation, four duration frameworks from thirty days to a full year, three complete programme templates with week-by-week dosing, demographic programme adjustments, the eleven-component client action plan, the thirty, ninety and one hundred and eighty day review structures, six required documents, and the retention conversations that decide whether anyone finishes.

Module 7: Advanced Clinical Protocols and Case Management

Ten red flag presentations requiring medical clearance, and seven condition-specific protocols covering Parkinson's disease, alcohol use disorder and addiction recovery, Long COVID and post-viral fatigue, severe menopausal syndrome, periodised athletic performance, traumatic brain injury rehabilitation support and metabolic syndrome. Plus the full adverse event profile with incidence and management, and the one-page GP letter structure that builds a referral relationship.

Module 8: Business Integration, Revenue Models and Practice Growth

The NADclinic partner model, nine layered revenue streams, four-tier membership design and the retention behaviours that sustain it, cost-based and value-based pricing from your own break-even, ASA CAP Code and MHRA marketing compliance applied to real copy, GP and corporate referral strategy, the six metrics that describe practice health, clinical environment requirements including indemnity, and digital presence essentials.

Module 9: Governance, Safety, Ethics and Regulatory Compliance

The UK regulatory landscape across MHRA, CQC, ASA, ICO, professional regulators and anti-doping, MHRA classification and Patient Group Directions, informed consent to the Montgomery standard, UK GDPR and special category data, scope of practice by registration, the seven pillars of clinical governance, significant event analysis and complaints management, the ethical pressure points of longevity medicine, professional development, and the clinical governance folder.